QSAM Biosciences Current ratio
Qual é o Current ratio de QSAM Biosciences?
O Current ratio de QSAM Biosciences, Inc. é 0.23
Qual é a definição de Current ratio?
O índice atual é um índice de liquidez que mede se uma empresa possui ou não recursos suficientes para cumprir suas obrigações de curto prazo.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio de empresas na Setor Health Care em OTC em comparação com QSAM Biosciences
O que QSAM Biosciences faz?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Empresas com current ratio semelhantes a QSAM Biosciences
- Imagicaaworld Entertainment tem Current ratio de 0.23
- Orisun Acquisition tem Current ratio de 0.23
- Postal Savings Bank of China Co tem Current ratio de 0.23
- Postal Savings Bank of China Co tem Current ratio de 0.23
- Punjab Alkalies & Chemicals tem Current ratio de 0.23
- YPB tem Current ratio de 0.23
- QSAM Biosciences tem Current ratio de 0.23
- Ion tem Current ratio de 0.23
- Angkor Resources tem Current ratio de 0.23
- Mobecom tem Current ratio de 0.23
- BlackRock World Mining Trust Plc tem Current ratio de 0.23
- African Discovery tem Current ratio de 0.23
- Bubblr Inc tem Current ratio de 0.23